Option Care Health (NASDAQ:OPCH) Issues Earnings Results

Option Care Health (NASDAQ:OPCH) issued its earnings results on Tuesday. The company reported $0.46 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.46, Briefing.com reports. Option Care Health had a net margin of 3.78% and a return on equity of 17.89%. The company had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion. During the same quarter last year, the business posted $0.44 EPS. The company’s revenue for the quarter was up 8.8% on a year-over-year basis.

Here are the key takeaways from Option Care Health’s conference call:

• Strong 2025 financials — net revenue of $5.6B (+13%), adjusted EBITDA of $471M (+6%), adjusted diluted EPS of $1.72 (+9%), operating cash flow of $258M and net leverage ~2.0x.
• Stelara biosimilar conversion is a material headwind — company absorbed ~160 bps of revenue pressure in 2025 and expects a ~400‑bp revenue headwind and a $25M–$35M gross profit/EBITDA impact in 2026, paced evenly through the year (Q1 comps may be tougher).
• Management reaffirmed its 2026 guidance — revenue of $5.8B–$6.0B, adjusted EBITDA of $480M–$505M, adjusted EPS of $1.82–$1.92, and an operating cash flow target of >$340M (>30% YoY cash growth target).
• Continued operational progress and efficiency gains — expanded infusion suites/clinics (Intramed Plus drove >25% clinic visit growth), ~34% of nursing visits now in suites/clinics, ~40% of claims processed without human intervention, and SG&A leverage (down 50 bps to 12.1%).
• Capital allocation discipline — repurchased >$300M of stock in 2025 and board authorized an additional $500M buyback; Intramed Plus integration beat expectations and tuck‑in M&A remains a focus while CapEx is planned to remain modest (~$40M–$50M).

Option Care Health Stock Performance

Option Care Health stock traded down $2.17 on Tuesday, reaching $33.92. 3,338,840 shares of the stock were exchanged, compared to its average volume of 1,801,469. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. Option Care Health has a twelve month low of $24.24 and a twelve month high of $36.80. The firm has a fifty day moving average price of $33.97 and a two-hundred day moving average price of $30.47. The stock has a market cap of $5.38 billion, a PE ratio of 26.92, a PEG ratio of 2.13 and a beta of 0.84.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on OPCH. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a research report on Monday, December 29th. Wall Street Zen upgraded Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, January 10th. Truist Financial set a $40.00 target price on shares of Option Care Health in a research note on Tuesday, January 13th. Bank of America boosted their target price on shares of Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a research report on Tuesday, December 9th. Finally, Barrington Research raised their price target on shares of Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a report on Friday, January 16th. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $37.58.

Institutional Trading of Option Care Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OPCH. Advisory Services Network LLC bought a new stake in Option Care Health in the third quarter valued at about $35,000. McIlrath & Eck LLC bought a new stake in shares of Option Care Health in the 2nd quarter valued at approximately $37,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Option Care Health in the 3rd quarter worth approximately $38,000. Quarry LP raised its holdings in shares of Option Care Health by 502.7% in the 3rd quarter. Quarry LP now owns 1,549 shares of the company’s stock worth $43,000 after buying an additional 1,292 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Option Care Health by 528.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after buying an additional 1,183 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.